A CHOC neurosurgeon explains effective surgical interventions, including laser ablation, RNS and DBS for the treatment of refractory pediatric epilepsy.
NICU quality improvement projects yield measurable outcomes
CHOC’s NICU patients benefit from quality improvement initiatives to ensure consistent neonatal care and enable swift response to QI results.
New surveillance program for congenital heart disease patients yields vast improvements in neurodevelopmental care
The Cardiac Neurodevelopmental Clinic (CNC) at CHOC’s Heart Institute is helping patients like Grace make vast improvements with their neurodevelopment.
CHOC study finds COVID-19 infection in newborns, though rare, may result in severe disease
CHOC’s study published in the Pediatrics journal finds that though COVID-19 infections in newborns are rare, they may cause severe disease.
New clinic and study site for patients with rare syndrome Fragile X opens in Thompson Autism and Neurodevelopmental Center
The Fragile X Clinic at CHOC will be devoted to the diagnosis, treatment, and study of the rare genetic condition of Fragile X syndrome.
CHOC conducts clinical trial for Glycogen Storage Disease type 1a
CHOC selected as West Coast site for gene therapy clinical trial for patients 8 years and older with Glycogen Storage Disease type 1a.
